Howe & Rusling Inc Durect Corp Transaction History

Howe & Rusling Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 15, 2020	SELL	$1.33 - $2.76 $4,692 - $9,737	-3,528 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$0.51 - $0.86 $867 - $1,462	1,700 Added 93.0%	3,528 $2,000
Q1 2019 Apr 29, 2019	BUY	$0.51 - $0.82 $3 - $5	7 Added 0.38%	1,828 $1,000
Q4 2018 Feb 04, 2019	BUY	$0.48 - $1.1 $289 - $664	604 Added 49.63%	1,821 $1,000
Q1 2018 May 14, 2018	SELL	$0.91 - $2.24 $212 - $521	-233 Reduced 16.07%	1,217 $3,000

Q3 2017 Oct 18, 2017	BUY	$1.55 - $1.82 $2,247 - $2,639	1,450	1,450 $3,000

559K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $280M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

Stay updated on Howe & Rusling Inc with notifications on news.